About Christopher Cashman
Christopher Cashman is a director at EpiVario.
Christopher Cashman reports to the SEC as a director or officer of 1 public company: Marinus Pharmaceuticals (MRNS).
Christopher Cashman first appears on SEC filings in 2014.
Experience
This experience comes from Christopher Cashman's profile and from SEC filings. For roles taken from filings, the years are when the filings name Christopher Cashman in the role, so the role may have started earlier or lasted longer.
EpiVario Inc. Current
Director
2024 – Present · Philadelphia, PA
Develops potential treatments for people with substance use and other psychiatric disorders.
TT
Telesis Therapeutics Current
Director
2021 – Present
MP
Mentor Connect PHL Current
Member
2019 – Present
MI
Marinus Pharmaceuticals, Inc.
Chairman and CEO
2011 – 2019 · Public company (MRNS)
NO
Novartis
President, Protez Pharmaceuticals
2008 – 2010
PP
Protez Pharmaceuticals
Co-Founder, CEO
2003 – 2008
MP
Message Pharmaceuticals
President and CEO
2002 – 2006
PF
Pfizer
Vice President
1995 – 2002
SB
SmithKline Beecham
Vice President
1980 – 1995
Key Colleagues at Startups
The people Christopher Cashman works with at each company, as listed on that company's latest Form D.
EpiVario Inc. · Form D, Oct 13, 2026
TK
Thomas Kim
President & CEO, director
ES
Eric Schultenover
Director